International shows are taking over Netflix and here are three series to add to your watch list - you won't want to miss them ...

A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.

Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over ...

Empagliflozin, which in addition to treating type-2 diabetes, also aids weight loss, and reduces cardiovascular and kidney ...

This follows the final approval from the US FDA for its abbreviated new drug application (ANDA). Shares of Lupin Ltd ended at ...

From 2019 to today, a variety of delightful new shōnen anime like, Demon Slayer, have hit the airwaves to carry on the torch ...

The Au Pair is about to air on Channel 5 and it follows a bespoke dressmaker who hires an au pair named Sandrine. While it ...

Lupin announced that it has launched Rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...

Stocks like India Pesticides, HFCL, NDR Auto Components, JSW Steel, GR Infraprojects, Biocon, Oil and Natural Gas Corporation ...

Lupin 's Omar Sy has been cast in a new Netflix offshoot of a popular action franchise. The star will lead a "high-octane" ...

Jefferies backs Lupin, Zydus, and Biocon amid shifting US pharma market shares. Discover why these stocks are set to shine.

Quarterly Net Profit at Rs. 855.16 crore in December 2024 up 39.48% from Rs. 613.12 crore in December 2023. EBITDA stands at ...